Faculty willing to give educational talks in Boston and surrounding communities about prevention, brain health, warning signs for Alzheimer’s disease and opportunities for clinical trials. To request a MADRC speaker for an upcoming event, complete this form: http://bit.ly/36Z3LwZ
Jess joined MGH Neurology as Dr. Steven Arnold’s Research Program Manager. She oversees protocol start-up activities for studies primarily focused on the identification and prevention of Alzheimer’s Disease. In addition, Jess is the Program Manager for the newly formed MGH Interdisciplinary Brain Center. The IBC is both a state of the art Clinical and Translational Research Unit and an academic collaboration between the MGH Departments of Neurology, Psychiatry and MGH Martinos Center for Biomedical Imaging. Jess is also helping to develop a common assessment that all subjects participating in research at the CTRU could take part in; eventually she will help organize access to this data for researchers from all over the globe.
Jess’s original education and professional development were in the field of manufacturing engineering; however, all along she had an interest in integrative health and decided to pursue a career as an acupuncturist. After owning a clinic in which she saw 60+ patients per week, she transitioned over to the MGH Martinos Center and got her start in research as a research acupuncturist. Her role was to provide acupuncture therapy services to subjects enrolled in ongoing clinical and basic research studies both inside and outside the MRI scanner; and she continues to consult on NIH Program Project Grants and other clinical trials for the Martinos Center as needed. Jess also sees acupuncture patients at the BWH Pain Center.
Jess looks forward to continued collaborations with researchers of all backgrounds to further support the MGH IBC mission which is to facilitate and synergize research for brain disorders.
Clinical Trials Nurse, Brigham and Women's Hospital
Kirsten Glennon is a certified neuroscience nurse in the Center for Alzheimer Research and Treatment (CART) at Brigham and Women’s Hospital. After 10 years of working with neurology patients in Boston area hospitals, Kirsten began working as a research nurse coordinating Alzheimer Disease (AD) studies and helping to run multiple AD clinical trials. Kirsten believes that CART AD clinical trials help to create a meaningful environment focused on AD prevention and treatment for those with memory concerns, memory impairment and for caregivers. She is passionate about being part of a team that seeks to raise awareness about the importance of clinical trials and clinical trial participation, as well as optimizing the clinical trial experience for research participants and their caregivers. Kirsten has a BA from University of Vermont and a BSN from Simmons College.
Behavioral Neurologist, Massachusetts General Hospital
Additional Languages Spoken: French, English, Spanish, Dutch
Bernard Hanseeuw is a behavioral neurologist. He obtained his MD, PhD in Belgium before moving to Boston. Since September 2014, he works as a postdoctoral research fellow at Massachusetts General Hospital. His research intends to understand the relationships between brain pathologies and cognitive deficits in normal aging and age-related disease, with a special focus on early detection of Alzheimer's disease. He has a special interest in brain imaging, particularly in amyloid, tau, and other PET imaging techniques. He aims to offer better care to patients with or at-risk for memory decline, and help the search of a cure, to keep longer the most precious gift we all have: our brain.
Director, Massachusetts Alzheimer's Disease Research Center
John B. Penney Jr. Professor of Neurology, Harvard Medical School
Brad Hyman is the John B. Penny, Jr. Professor of Neurology at Harvard Medical School. He directs the Alzheimer’s unit at Mass General Institute for Neurological Disease (MIND), with the goal of understanding the neuropathophysiologic and genetic factors that underlie dementia. Dr. Hyman’s laboratory studies the anatomical and molecular basis of dementia in Alzheimer’s disease and dementia with Lewy bodies.
Dr. Hyman received his M.D. and Ph.D. from University of Iowa, and he has received the Metropolitan Life Award, the Potamkin Prize, an NIH Merit award, and an Alzheimer’s Association Pioneer Award. He is the current director of the Massachusetts Alzheimer’s Disease Research Center.
Co-Director of Primary Care Outreach
Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital
Massachusetts Alzheimer's Disease Research Center, Massachusetts General Hospital
Lenore is the Co-Director of Primary Care Outreach at the Center for Alzheimer Research and Treatment and the Massachusetts Alzheimer’s Disease Research Center. She is instrumental in educating primary care physicians about the warning signs of Alzheimer’s disease and direct referral networks. Lenore is the former Manager of Research and Medical Education at the Massachusetts/New Hampshire Chapter of the Alzheimer’s Association, and has supported clinical research operations for over 30 years. She is an Adjunct Faculty Member at Emmanuel College in the Graduate and Professionals Management Program, and a registered nurse who has worked in both acute and long-term care settings. Lenore is passionate about the importance of clinical trial participation and is forever grateful to the many wonderful research volunteers she has been privileged to work with over the years.
Scientist, Ann Romney Center for Neurologic Diseases, Brigham & Women's Hospital
Associate Professor of Neurology, Harvard Medical School
Dr. Lemere focuses on translational research for understanding, preventing and treating Alzheimer's disease. Dr. Lemere earned a bachelor’s degree in Psychology and Education from Mount Holyoke College and a master’s in Neurobiology from SUNY Albany. Dr. Lemere examined Alzheimer's-related brain changes in people with Down syndrome in the Selkoe Laboratory at Brigham and Women's Hospital while pursuing her doctorate in Pathology at Boston University School of Medicine. After receiving her Ph.D., she remained at the Center as a Postdoctoral Research Fellow, Instructor, Assistant Professor and is currently an Associate Professor in the Department of Neurology. Her current research involves: a) preclinical studies of antibody-treatments and vaccines, with and without focused ultrasound treatments, to reduce a disease-relevant form of the amyloid-beta protein that accumulates and forms plaques in the Alzheimer’s brain; b) the role of the body’s immune host-defense system (e.g., complement) in Alzheimer’s disease progression; and, c) the effects of deep space galactic cosmic radiation on brain aging and the risk of Alzheimer’s in preparation for NASA’s first manned mission to Mars in the 2030s. Dr. Lemere participates in local and national mentoring programs for underrepresented minorities including high school, undergraduate and medical students. Dr. Lemere serves on several national and international scientific advisory boards, including the National Alzheimer’s Association Medical and Scientific Advisory Council, the Dominantly Inherited Alzheimer’s Network Therapeutic Unit (DIAN-TU) Therapeutic Evaluation Committee, the International Alzheimer’s Disease/Parkinson’s Disease (ADPD) Conference Scientific Advisory Council, the BrightFocus Foundation Scientific Review Council and the DownSyndrome Achieves Biobank Governing Board of Directors. In addition, she serves as a scientific advisor for several companies
Associate Medical Director of Clinical Trials, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Massachusetts General Hospital
Associate Professor of Neurology, Harvard Medical School
Gad Marshall is board certified in Neurology. He is currently the Associate Medical Director of Clinical Trials at the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital; Associate Neurologist at Brigham and Women’s Hospital; Assistant in Neurology at Massachusetts General Hospital; and Assistant Professor of Neurology at Harvard Medical School. Dr. Marshall has been site principal investigator for multiple clinical trials of amyloid-modifying drugs in Alzheimer’s disease and is currently the site principal investigator for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 3, DoD-ADNI, and the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) trial. His research has focused on clinical correlates of activities of daily living and neuropsychiatric symptoms with multiple imaging markers and cerebrospinal fluid biomarkers across the early Alzheimer’s disease spectrum, as well as developing novel, sensitive, and ecologically-valid assessments for early functional changes in Alzheimer's disease.
Assistant Professor of Neurology, Harvard Medical School
Scott McGinnis is a a behavioral neurologist at the BWH Center for Brain Mind Medicine, an investigator in the BWH Center for Alzheimer Research and Treatment and an investigator in the MGH Frontotemporal Disorders Unit. He completed his residency in neurology in the MGH/BWH program and a fellowship in behavioral neurology and neuropsychiatry at BWH. Dr. McGinnis’ career comprises patient care, education of students, residents, and fellows, and clinical research studies on aging and neurodegenerative dementias. His research interests include atypical presentations of Alzheimer disease and non-Alzheimer cognitive neurodegenerative disorders.
Dr. McManus is board certified as a Family Nurse Practitioner and Principal Investigator within the Department of Neurology at Massachusetts General Hospital (MGH). Dr. McManus graduated as a Registered Nurse in 1987 and subsequently became Certified in both Intensive Care and Emergency Nursing. She received an MSN as a Family Nurse Practitioner from the University of San Diego and a Doctorate in Nursing Practice from Rush University in Chicago.
Dr McManus is the Clinical Research Nurse Manager of the Alzheimer’s Clinical & Translational Research Unit (ACTRU) at MGH. Her work broadly involves the management of translational and clinical trial activities at the ACTRU. She supervises the conduct of sponsor and investigator-initiated trials, as well as the clinical care of patients enrolled in clinical research projects, within the ACTRU. Dr McManus is one of only a handful of Nurse Practitioners in the nation who are leading these types of clinical drug trials as a Principal Investigator.
Martha received her Bachelor of Arts in Psychology (’08) and Master of Arts in Psychology (’12) degrees from San Diego State University and Boston University, respectively. She has worked in public health research (Hispanic Community Health Study/Study of Latinos), aging and Alzheimer’s disease research at the University of California (San Diego), and has been a research coordinator at the Harvard Aging Brain study (HABS) since 2016. Currently, she assists in data collection, outreach efforts, and coordinates the newly funded Spanish speaking cohort of HABS. She is excited to continue learning about aging and cognition in older adults within and outside the Latino community.